Figure 1
From: Alterations in the kallikrein-kinin system predict death after heart transplant

Study overview. Patient’s blood were drawn and serum was processed according to protocol at the clinical site (see “Methods”). We employed Monte Carlo Cross Validation (MCCV; See “Methods” for complete algorithm) to quantify a prediction interval of all pre-transplant, recipient markers to predict patient survival after heart transplantation. Additionally, the eligible protein markers were used in a differential protein expression analysis. Figure made with Biorender.